Abu Dhabi:The Department of Health - Abu Dhabi (DoH) has successfully wrapped up its inaugural health and life sciences mission to China. This mission focused on advancing collaborations in artificial intelligence, precision medicine, and next-generation therapies to enhance health outcomes.

According to Emirates News Agency, the mission involved 32 meetings and site visits in Beijing, Shanghai, and Shenzhen. It aimed to connect Abu Dhabi's healthcare ecosystem with leading Chinese institutions and innovators. The discussions highlighted opportunities for joint research, clinical studies, and technology adoption, leveraging China's scientific capabilities and Abu Dhabi's healthcare infrastructure.

Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, emphasized the importance of integrating scientific discoveries with healthcare access. She noted that the mission identified opportunities to develop partnerships that could improve health outcomes in Abu Dhabi, China, and globally.

The delegation also explored next-generation treatments and discussed advancements in cell therapies, biologics, and drug discovery. There was a focus on how Abu Dhabi's diverse patient population and genomic capabilities could support the validation of these treatments.

The mission further examined the potential for clinical evaluation and development of AI, surgical robotics, and advanced imaging technologies. Precision oncology was a key focus, with discussions on integrating Chinese innovations with Abu Dhabi's genomic and health-data infrastructure to transform cancer care.

The relationships formed during this mission will continue through the Abu Dhabi Future Health Summit 2026. This summit will provide a platform for transitioning discussions into concrete partnerships and projects.

The mission aligns with Abu Dhabi's goal to be a globally connected platform for life sciences, facilitating the development and scaling of healthcare innovations.